| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/25/1998 | EP0830140A1 A pluripotent vaccine against enveloped viruses |
| 03/25/1998 | EP0830139A1 Modified myelin protein molecules |
| 03/25/1998 | EP0830138A1 Use of fibroblast growth factors to stimulate bone growth |
| 03/25/1998 | EP0830137A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 03/25/1998 | EP0830130A1 Tnf-alpha converting enzyme |
| 03/25/1998 | EP0830087A2 Method for laser mediated tissue welding with enhanced strength |
| 03/25/1998 | EP0830061A1 Moist bacteriocin disinfectant wipes and methods of using the same |
| 03/25/1998 | EP0624163B1 Cyclic calcitonin derivatives and method for their production |
| 03/25/1998 | CN1177381A Process for producing phosphatidylserines having polybasic unsaturated fatty acid and as side chain |
| 03/25/1998 | CN1177378A Stabilized external guide sequences |
| 03/25/1998 | CN1177342A Novel cationic lipids and the use thereof |
| 03/25/1998 | CN1177303A Application of lysozyme dimer |
| 03/25/1998 | CN1177302A Lymphotoxin- |
| 03/25/1998 | CN1177005A Method for gene clone of inhibitory factor for hyperplasia of inner blood vessel cells in human body's real tumor, and using same to anti tumer blood vessel regeneration |
| 03/25/1998 | CN1176826A Cyclosporin-containing topical pharmaceutical compostion |
| 03/25/1998 | CN1037857C Method for preparing peptide derivatives by using black chain mould |
| 03/25/1998 | CN1037845C Method for preparing stable bioactive somatotropine |
| 03/25/1998 | CN1037844C Tnf-muteins |
| 03/25/1998 | CN1037816C Process for preparing dicarbonhydrase mini-capsule having function of protecting digestive tract |
| 03/25/1998 | CA2216439A1 Pharmaceuticals containing retinal stem cells |
| 03/24/1998 | US5731439 Piperidine containing aminobornic acids |
| 03/24/1998 | US5731428 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 03/24/1998 | US5731427 Nucleic acids encoding a gap-associated protein |
| 03/24/1998 | US5731426 Phaseolus α-D-galactosidases |
| 03/24/1998 | US5731420 Antibodies to human I-branching beta-1,6-N-acetylglucosaminyltransferase |
| 03/24/1998 | US5731415 Lipopolysaccharide binding protein derivatives |
| 03/24/1998 | US5731413 Liquid or solid phase biosynthesis |
| 03/24/1998 | US5731411 Promotion of homologous DNA pairing by RecA-derived peptides |
| 03/24/1998 | US5731410 Neurological disorders |
| 03/24/1998 | US5731340 Dietetics; antidiabetic agents |
| 03/24/1998 | US5731312 Administering mixture of dopamine antagonist and prolactin inhibitor |
| 03/24/1998 | US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 03/24/1998 | US5731295 Method of reducing stromelysin RNA via ribozymes |
| 03/24/1998 | US5731294 Inhibition of neovasularization using VEGF-specific oligonucleotides |
| 03/24/1998 | US5731289 Bridged dipeptide compounds which have a stimulating activity on cell division, especially in myelopoietic and bone marrow cells |
| 03/24/1998 | US5731288 Compositions containing contortrostatin and methods for the use thereof |
| 03/24/1998 | US5731287 Prolactin |
| 03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
| 03/24/1998 | US5731285 Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 03/24/1998 | US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product |
| 03/24/1998 | US5731200 Isolated nucleic acid encoding receptor-like TGF-β1 binding protein |
| 03/24/1998 | US5731192 Collagen COL4A6: gene, protein and method of detecting collagen deficiency |
| 03/24/1998 | US5731190 Penton base protein and methods of using same |
| 03/24/1998 | US5731187 Process for preparing hepatitis A (HAV) antigens and vaccines |
| 03/24/1998 | US5731186 Purification using cation exchange resin; chromatography |
| 03/24/1998 | US5731170 DNA encoding a growth factor specific for epithelial cells |
| 03/24/1998 | US5731168 Method for making heteromultimeric polypeptides |
| 03/24/1998 | US5731167 Dna segment coding for a polypeptide |
| 03/24/1998 | US5731166 Recombinant production of chemotactic CP-10 polypeptides and therapeutic methods using them |
| 03/24/1998 | US5731159 Heat stable receptor protein contacted with detectable antibodies |
| 03/24/1998 | US5731155 Compositions for inhibition of intracellular transcription factors and methods therefor |
| 03/24/1998 | US5731151 Tuberculosis vaccine |
| 03/24/1998 | US5731149 Antibiotic cryptdin peptides and methods of their use |
| 03/24/1998 | US5731008 Electrically hydrolyzed salines as microbicides |
| 03/24/1998 | US5730998 Administering substance p antagonist |
| 03/24/1998 | US5730990 Non-antigenic amine derived polymers and polymer conjugates |
| 03/24/1998 | US5730985 Methyl ecgonine phenylphosphonate as chemical intermediate of cocaine |
| 03/24/1998 | US5730983 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 03/24/1998 | US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof |
| 03/24/1998 | US5730981 Monoclonal anti-ganglioside antibody and its preparation |
| 03/24/1998 | US5730980 Methods and compositions for ameliorating the symptoms of sepsis |
| 03/24/1998 | US5730979 LO-CD2a antibody and uses thereof for inhibiting T cell activation and proliferation |
| 03/24/1998 | US5730978 Inhibition of lymphocyte adherence with α4β1-specific antibodies |
| 03/24/1998 | US5730977 Anti-VEGF human monoclonal antibody |
| 03/24/1998 | US5730976 Method for treating macrophage pathogen infections by TGF-B antagonists |
| 03/24/1998 | US5730975 Treatment of insulin resistance in obesity linked type II diabetes using antagonist to TNF-alpha function |
| 03/24/1998 | US5730971 Mixture of flavin adenine dinucleotide and porcien liver extract |
| 03/24/1998 | US5730970 Pharmaceutical compositions comprising human interleukin-4 (IL-4) |
| 03/24/1998 | US5730969 Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
| 03/24/1998 | CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy |
| 03/24/1998 | CA1339777C Superoxide dismutase polymers |
| 03/24/1998 | CA1339776C Equine-gamma-interferon |
| 03/24/1998 | CA1339772C Method for separating long-chain nucleic acid |
| 03/20/1998 | CA2185950A1 Process for preparing intermediates for thrombin inhibitors |
| 03/19/1998 | WO1998011256A1 Beclin, a novel bcl-2 interacting gene near brca1 on chromosome 17q21 and methods of use |
| 03/19/1998 | WO1998011254A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA (α), HNF-1β AND HNF-4$g(a) |
| 03/19/1998 | WO1998011246A2 ENDO-β-GALACTOSIDASE |
| 03/19/1998 | WO1998011245A1 Sustained delivery device and methods of making and using the same |
| 03/19/1998 | WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
| 03/19/1998 | WO1998011241A1 Oligocistronic expression system for the production of heteromeric proteins |
| 03/19/1998 | WO1998011238A2 Protease m, a novel serine protease |
| 03/19/1998 | WO1998011236A1 Aspartic protease |
| 03/19/1998 | WO1998011234A2 Human protein kinases |
| 03/19/1998 | WO1998011233A1 Novel human phosphorylase kinase gamma subunit |
| 03/19/1998 | WO1998011232A2 Human nm23-like protein |
| 03/19/1998 | WO1998011227A1 Granulocyte chemotactic protein 2 variant |
| 03/19/1998 | WO1998011226A2 Mammalian chemokines, related reagents |
| 03/19/1998 | WO1998011225A2 A novel haemopoietin receptor and genetic sequences encoding same |
| 03/19/1998 | WO1998011224A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods |
| 03/19/1998 | WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 03/19/1998 | WO1998011222A1 Screening methods for compounds useful in the treatment of schizophrenia |
| 03/19/1998 | WO1998011221A2 Car, a novel coxsackievirus and adenovirus receptor |
| 03/19/1998 | WO1998011220A2 Novel human cell division cycle proteins |
| 03/19/1998 | WO1998011219A1 Disease associated membrane protein (damp) |
| 03/19/1998 | WO1998011218A1 Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
| 03/19/1998 | WO1998011216A1 Novel semaphorin gene: semaphorin y |
| 03/19/1998 | WO1998011213A1 Method for treating amyotrophic lateral sclerosis |
| 03/19/1998 | WO1998011212A1 Ptx sensitive g proteins, the production and use thereof |
| 03/19/1998 | WO1998011211A2 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES |
| 03/19/1998 | WO1998011208A1 Method for preparing a plasmid dna |